The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis
Abstract
Objective. To investigate the effectiveness and side effects of oral versus pulse cyclophosphamide (CYC) in combination with corticosteroids (CS) in the treatment of systemic Wegener's granulomatosis (WG). Methods. Patients with newly diagnosed systemic WG were enrolled in a prospective, randomized trial. At the time of diagnosis, prior to randomization, every patient received a daily injection of methylprednisolone for 3 days, followed by daily oral prednisone (1 mg/kg/day) and a 0.7‐gm/m 2 pulse of CYC. Patients were then randomly assigned to receive either prednisone plus intravenous pulse CYC (group A) or prednisone plus oral CYC (group B) as first‐line treatment. CYC was given for at least 1 year and was then progressively tapered and discontinued. Results. Fifty patients were included in the study: 27 in group A and 23 in group B. At 6 months, 24 group A patients (88.9%) were in remission, versus 18 group B patients (78.3%). At the end of the trial, 18 group A patients (66.7%) and 13 group B patients (56.5%) were in remission. In group A, 66.7% of the patients experienced side effects, versus 69.6% in group B. Infectious side effects were significantly more frequent in group B (69.6%) than in group A (40.7%) (P < 0.05). The incidence of Pneumocystis carinii pneumonia was higher in oral CYC‐treated patients (30.4%) than in pulse CYC‐treated patients (11.1%). Nine group A patients (33.3%) and 10 group B patients (43.5%) died. Actuarial curves showed that relapses were significantly more frequent in group A (59.2%) than in group B (13%) (P = 0.02). Conclusion. Our results indicate that pulse CYC is as effective as oral CYC in achieving initial remission of WG and is associated with fewer side effects and lower mortality. However, in the long term, treatment with pulse CYC does not maintain remission or prevent relapses as well as oral CYC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Wegener Granulomatosis: An Analysis of 158 Patients
Hoffman, G. S., Kerr, G. S., Leavitt, R. Y., Hallahan, C. W., Lebovics, R. S., Travis, W. D., Rottem, M., & Fauci, A. S. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-6-488 · Cited by 2,857
FAUCI, A. S., HAYNES, B. F., KATZ, P., & WOLFF, S. M. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-1-76 · Cited by 2,001
Leavitt, R. Y., Fauci, A. S., Bloch, D. A., Michel, B. A., Hunder, G. G., Arend, W. P., Calabrese, L. H., Fries, J. F., Lie, J. T., Lightfoot, R. W., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330807 · Cited by 1,947
Van Der Woude, F. J., Lobatto, S., Permin, H., Van Der Giessen, M., Rasmussen, N., Wiik, A., Van Es, L. A., Van Der Hem, G. K., & The, T. H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91147-x · Cited by 1,885
Stegeman, C. A., Cohen Tervaert, J. W., de Jong, P. E., & Kallenberg, C. G. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350103 · Cited by 777
Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis
Talar-Williams, C., Hijazi, Y. M., Walther, M. M., Linehan, W. M., Hallahan, C. W., Lubensky, I., Kerr, G. S., Hoffman, G. S., Fauci, A. S., & Sneller, M. C. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-5-199603010-00003 · Cited by 537
Cyclophosphamide Therapy of Severe Systemic Necrotizing Vasculitis
Fauci, A. S., Katz, P., Haynes, B. F., & Wolff, S. M. (1979) · New England Journal of Medicine · doi:10.1056/nejm197908023010503 · Cited by 526
Falk, R. J., Hogan, S., Carey, T. S., Jennette, J. C., & The Glomerular Disease Collaborative Network (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-9-656 · Cited by 391
An analysis of forty‐two wegener's granulomatosis patients treated with methotrexate and prednisone
Sneller, M. C., Hoffman, G. S., Talar‐Williams, C., Kerr, G. S., Hallahan, C. W., & Fauci, A. S. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380505 · Cited by 265
Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.
Godeau, B., Coutant-Perronne, V., Huong, D. U. L. T., Guillevin, L., Magadur, G., Bandt, M. D., Dellion, S., Rossert, J., Rostoker, G., & Pietté, J. C. (1994) · PubMed · Cited by 254
Self-citationOgnibene, F. P., Shelhamer, J. H., Hoffman, G. S., Kerr, G. S., Reda, D., Fauci, A. S., & Leavitt, R. Y. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.3.7881673 · Cited by 210
Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide
Hoffman, G. S., Leavitt, R. Y., Fleisher, T. A., Minor, J. R., & Fauci, A. S. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90367-m · Cited by 201
Reinhold‐Keller, E., Kekow, J., Schnabel, A., Schmitt, W. H., Heller, M., Beigel, A., Duncker, G., & Gross, W. L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370622 · Cited by 166
Infectious complications of cyclophosphamide treatment for vasculitis
Bradley, J. D., Brandt, K. D., & Katz, B. P. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320108 · Cited by 137
Infection and Immunosuppression
COHEN, J., Pinching, A. J., REES, A. J., & Peters, D. K. (1982) · QJM · doi:10.1093/oxfordjournals.qjmed.a067702 · Cited by 84
Immunosuppressive therapy of autoimmune diseases
Bach, J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90053-n · Cited by 71
Haga, H. J., D’Cruz, D. P., Asherson, R. A., & Hughes, G. R. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.7.885 · Cited by 53
Fort, J. G., & Abruzzo, J. L. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310918 · Cited by 25
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Jayne, D., Rasmussen, N., Andrassy, K., Bacon, P., Tervaert, J. W. C., Dadoniené, J., Ekstrand, A., Gaskin, G., Gregorini, G., de Groot, K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020286 · Cited by 1,348
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Yates, M., Watts, R. A., Bajema, I. M., Cid, M. C., Crestani, B., Hauser, T., Hellmich, B., Holle, J. U., Laudien, M., Little, M. A., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209133 · Cited by 1,194
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
Guillevin, L., Pagnoux, C., Karras, A., Khouatra, C., Aumaître, O., Cohen, P., Maurier, F., Decaux, O., Ninet, J., Gobert, P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404231 · Cited by 1,090
Self-citationJabs, D. A., Rosenbaum, J. T., Foster, C. S., Holland, G. N., Jaffe, G. J., Louie, J. S., Nussenblatt, R. B., Stiehm, E. R., Tessler, H., Van Gelder, R. N., et al. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00659-0 · Cited by 995
Metadata
- Authors
- Guillevin, L., Cordier, J., Lhote, F., Cohen, P., Jarrousse, B., Royer, I., Lesavre, P., Jacquot, C., Bindi, P., Bielefeld, P., Desson, J., Détrée, F., Dubois, A., Hachulla, E., Hoen, B., Jacomy, D., Seigneuric, C., Lauque, D., Stern, M., & Longy‐Boursier, M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1997-12
- Volume
- 40
- Issue
- 12
- Pages
- 2187-2198
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2073208829
- Cited by
- 509
- References
- 22
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.